Publications

Selected Publication (from 2015 onwards)
  1. Elora Khamrui, Sounak Banerjee, Subha Ray, Aishwarya Ray, Barun Mahata, Troyee Das, Zhumur Ghosh and Kaushik Biswas*. “Ganglioside GM2 induces epithelial-mesenchymal transition (EMT) in cancer cells in a MEK/ERK/Egr1-dependent transcriptional program.” J. Biol. Chem., epub ahead of print,  10.1016/j.jbc.2026.111306,  Feb 19, 2026.
  2. Sounak Banerjee1, Avisek Banerjee1, 2#, Subha Ray1#, Aishwarya Ray1, Debarati Paul1, Shubhra Ghosh Dastidar1, Belinda Willard3 and Kaushik Biswas*1., “dCas9 targeted proteome profiling reveals p300-mediated reciprocal regulation of SMAD and SP1 as a driver of GM2 synthase transcription in renal cell carcinoma”. FASEBJ, 2026, 40, e71597, 10.1096/fj.202502746R.
  3. “Emerging role of MAPK signaling in glycosphingolipid-associated
    tumorigenesis.” Khamrui, E., Banerjee, S., Mukherjee, D.D. and Biswas, K*. Glycoconjugate Journal, Oct 5, 2024, part of a collection “Tribute to Professor Sen-Itiroh Hakomori“, https://rdcu.be/dV8RK, https://doi.org/10.1007/s10719-024-10168-5
  4. “Non-Canonical Targets of MicroRNAs: Role in Transcriptional Regulation, Disease Pathogenesis and Potential for Therapeutic Targets.” Ray, A., Sarkar, A., Banerjee, S. and Biswas, K*. MicroRNA, 13(2), 83-95, Jan 22, 2024, 10.2174/0122115366278651240105071533
  5. “Multi-dimensional role of gangliosides in modulating cancer hallmarks and their prospects in targeted cancer therapy.” Sarkar, A., Banerjee, S. and Biswas, K*. Frontiers Pharmacol., 14, 2023, https://doi.org/10.3389/fphar.2023.1282572.
  6. “Eriodictyol mediated selective targeting of the TNFR1/FADD/TRADD axis in cancer cells induce apoptosis and inhibit tumor progression and metastasis.” Debnath, S., Sarkar, A., Mukherjee, D.D., Ray, S., Mahata, B., Mahata, T., Parida, P.K., Das, T., Mukhopadhyay, R., Ghosh, Z. and Biswas, K*. Translational Oncology, 2022, 21, 101433, 2022. https://doi.org/10.1016/j.tranon.2022.101433
  7. “Elevated Histone H3 Acetylation and Loss of the Sp1-HDAC1 Complex De-Repress the GM2-synthase Gene in Renal Cell Carcinoma.”Banerjee A, Mahata B, Dhir A, Mandal TK, Biswas K.*, J Biol Chem. 2019 Jan 18;294(3):1005-1018. DOI: 1074/jbc.RA118.004485
  8. “Inhibition of Cancer Progression by a Novel Trans-Stilbene Derivative Through Disruption of Microtubule Dynamics, Driving G2/M Arrest, and p53-dependent Apoptosis.” Parida PK, Mahata B, Santra A, Chakraborty S, Ghosh Z, Raha S, Misra AK, Biswas K.*, Jana K.* Cell Death Dis. 2018 May 1;9(5):448. (Joint Corresponding Author) https://doi.org/10.1038/s41419-018-0476-2
  9. “Regulation of Monoamine Oxidase A (MAO-A) Expression, Activity, and Function in IL-13-stimulated Monocytes and A549 Lung Carcinoma Cells.” Dhabal S, Das P, Biswas P, Kumari P, Yakubenko VP, Kundu S, Cathcart MK, Kundu M, Biswas K., Bhattacharjee A.* J Biol Chem. 2018 Sep 7;293(36):14040-14064. DOI: 1074/jbc.RA118.002321
  10. “Generation of Stable Knockout Mammalian Cells by TALEN-Mediated Locus-Specific Gene Editing.” Mahata B, Biswas K.* Methods Mol Biol. 2017;1498:107-120. DOI: 10.1007/978-1-4939-6472-7_7
  11. “Ganglioside GM2 mediates migration of tumor cells by interacting with integrin and modulating the downstream signaling pathway.” Manjari Kundu, BarunMahata, Avisek Banerjee, Sohini Chakrabarty, Shibjyoti Debnath, Sougata Sinha Ray, Zhumur Ghosh and Kaushik Biswas*, Biochim Biophys Acta – Mol Cell Res., 1863 (7 Pt A), 1472-1489, 2016. DOI: 1016/j.bbamcr.2016.04.004
  12. “TALEN mediated targeted editing of GM2/GD2-synthase gene modulates anchorage independent growth by reducing anoikis resistance in mouse tumor cells.” Barun Mahata, Avisek Banerjee, Manjari Kundu, Uday Bandyopadhyay and Kaushik Biswas*, Scientific Reports, 5, 9048, 2015. https://doi.org/10.1038/srep09048,